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identified in patients with punctate PPK.
Although PPK is a rare disorder, diseases
characterized by hyperkeratosis and
hyperproliferation are common, and
identification of the underlying cellular
mechanisms in this familial keratoderma
may contribute to our future ability to
understand and treat the more prevalent
hyperkeratotic diseases.
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TO THE EDITOR
Olmsted syndrome (OS; MIM 614594)
is a rare genodermatosis featuring
symmetric and mutilating palmoplantar
keratoderma (PPK) and periorificial ker-
atotic plaques (Olmsted, 1927). Diffuse
alopecia, onychodystrophy, oral leuco-
keratosis, corneal lesions, and pseudo-
ainhum may be associated as well
(Mevorah et al., 2005; Lai-Cheong
et al., 2012). Extracutaneous manifesta-
tions are uncommon and include
deafness, mental retardation, joint
laxity, osteopenia, and osteolysis, se-
condary infections, and squamous cell
carcinoma developing in areas of PPK
(Mevorah et al., 2005).
Although most cases reported to date
have been sporadic, both autosomal
dominant (Cambiaghi et al., 1995) and
X-linked recessive inheritance (Larregue
et al., 2000; Haghighi et al., 2013)
have been reported and shown to
be associated with mutations in
TRPV3 (MIM 607066) which encodes
the transient receptor potential
vanilloid 3 (Lai-Cheong et al., 2012;
Lin et al., 2012) and X-linked
MBTPS2 (MIM 300294), encoding the
membrane-bound transcription factor
protease, site 2, respectively (Haghighi
et al., 2013).
TRPV3 is highly expressed in kerati-
nocytes and in cells outlining hair
follicles (Valdes-Rodriguez et al.,
2013). It has an important role in
epidermal barrier formation (Cheng
et al., 2010), modulates hair growthAccepted article preview online 24 January 2013; published online 20 February 2014
Abbreviations: OS, Olmsted syndrome; PPK, palmoplantar keratoderma; RFLP, restriction fragment length
polymorphism; TRPV, vanilloid family of transient receptor potential
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regulation (Borbiro et al., 2011), and is
an important mediator of pain sensation
and pruritus (Huang et al., 2008;
Yamamoto-Kasai et al., 2012), which
correspond to all major clinical
manifestations of OS.
Herein, we identified a homozygous
recessive mutation in TRPV3 causing a
severe form of OS. The clinical features
of the proband have previously been
reported (Mevorah et al., 2005). In brief,
the proband was 2 years old when
initially seen in our department. She is
of Arab Muslim origin. Her parents were
asymptomatic and without any cutane-
ous abnormality on examination. They
denied consanguinity. Family history
was negative for any skin condition.
The patient presented with painful
and pruritic symmetric palmoplantar
keratoderma associated with marked
subungual hyperkeratosis, hyperkera-
totic plaques around the mouth, ear
meatus, nostrils, and anus, leukokera-
tosis of the tongue and of the buccal
mucosa, fingers deformities, and
difficulty in walking (Figure 1a and b).
Signs were first evident at the age of 6
months with continuous progression of
the disease through childhood. Histo-
pathological examination of skin bio-
psies revealed psoriasiform hyperplasia,
hypogranulosis, and alternating para-
keratosis, and orthohyperkeratosis. The
patient was treated with oral acitretin
and topical keratolytics and retinoids
with partial improvement.
Informed and written consent was
obtained from all participants before
enrollment into the study according to
a protocol approved by our institutional
review board and by the Israel National
Committee for Human Genetic Studies in
accordance with the principles of the
Declaration of Helsinki. DNA was
extracted from peripheral blood leuko-
cytes of the patient and her family mem-
bers. We PCR-amplified the entire coding
sequence of TRPV3. Direct sequencing of
the resulting amplicons revealed a homo-
zygous guanine-to-cytosine transition
at position 1562 (c.1562G4C) of the
TRPV3 cDNA (Figure 1c). This mutation
is predicted to result in the substitution of
a serine residue for tryptophan at amino-
acid position 521 (p.Trp521Ser). We
confirmed the presence of the mutation
in the proband using a PCR–restriction















Figure 1. Clinical features, molecular analysis, and protein modeling. (a) The patient displays diffuse, inflammatory, and symmetric plantar keratoderma as
well as (b) perioral hyperkeratotic plaques. (c) Direct sequencing revealed a homozygous guanine-to-cytosine substitution at position 1562 of TRPV3 cDNA
(c.1562G4C) in the proband (upper panel). The mutation is carried by both parents (middle panel) in a heterozygous state. The wild-type sequence is given for
comparison (lower panel). (d) PCR–restriction fragment length polymorphism analysis confirmed co-segregation of the mutation with the disease phenotype in the
family. Briefly, a 191 bp long PCR fragment was amplified from genomic DNA with forward primer 50-GAGTCTTGGTCCTGGGGAAG-30 and reverse primer
50-GATAACCAAGGGGCCAGACCTACTTACAAGACAAAGTGGCTC-30. The resulting amplicons were digested for one and a half hours with DNA endonuclease XhoI
(New England Biolabs, Ipswich, MA). Mutation c.1562G4C generates a new recognition site for DNA endonuclease XhoI at position 147 of the 191bp fragment. As a
result the patient displays a 147 bp fragment product, whereas her parents show both a wild-type (191 bp) and a cleaved (147 bp) fragment. Her uncle, who does not
carry the mutation, demonstrates the 191bp fragment only. (e) We modeled the TRPV3 tetramer using SWISS-Model folding engine (Arnold et al., 2006). The
G573 residue (involved in previously reported dominant mutations p.G573S and p.G573C (Lin et al., 2012) and located within the S4–S5 linker domain) is represented
with red spheres and is located within the core of the protein. The W521 residue (involved in recessive mutation p.Trp521Ser and located within the S2–S3 linker
domain) is represented with blue spheres and is located outside the channel opening. TRPV, vanilloid family of transient receptor potential; WT, wild type.
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Despite the fact that this mutation has
not yet been reported, a number of facts
support the possibility that it causes OS.
First, the mutation was found to co-
segregate with the disease phenotype
in the family (Figure 1d). Second, using
the PCR–RFLP assay described above,
we excluded the mutation from a panel
of 250 (500 chromosomes) population-
matched healthy individuals. Third, the
mutation was absent from the 1000
Genomes Project and the NHLBI
Grand Opportunity Exome Sequencing
Project databases including more than
6,500 individual sequences. Fourth, the
mutation affects a highly conserved resi-
due (Conservation score by Conseq¼7,
range 1–9; http://conseq.tau.ac.il/). Fifth,
accordingly, the Poly-Phen-2 (http://
genetics.bwh.harvard.edu/pph2/index.
shtml) protein function prediction brow-
ser attributes to the mutation a very high
score (1, range 0–1).
Finally, we used protein modeling in
an attempt to better understand the
consequences of the mutation we iden-
tified. The fact that OS encompasses
diverse inheritance patterns led us to
hypothesize that recessive mutations
may have a different effect on the pro-
tein function as compared with hetero-
zygous mutations in TRPV3. TRPV3
encodes a voltage-thermo-sensitive cha-
nnel, which is a member of the vanilloid
family of transient receptor potential
(TRPV) channels (Nilius et al., 2013).
The mature channel results from tetra-
merization (Chung et al., 2004; Doerner
et al., 2011), suggesting that the muta-
tion may either affect oligomerization or
inhibit the function of assembled mutant
channels. Using the SWISS-Model
folding engine (Arnold et al., 2006), we
compared the recessive p.Trp521Ser
mutation identified in the present study
with the previously reported dominant
mutation p.G573S (Lai-Cheong et al.,
2012; Lin et al., 2012). p.G573S occurs
at a position that has multiple structural
consequences. The mutation (Figure 1e;
red spheres), which results in the sub-
stitution of a large serine residue for a
small glycine residue, affects a 90-
degree kink on an alpha helix that
bridges between helical bundles. It thus
could easily interfere with protein
folding or oligomerization, and is
located in the central area of the tetra-
mer. The recessive p.Trp521Ser muta-
tion reported in this report leads to
replacement of a bulky residue with a
small polar one, but affects a more
peripheral domain of the protein
(Figure 1e, blue spheres). These differ-
ences may explain why heterozygous
p.Trp521Ser does not seem to exert a
clinically significant effect on protein
function as attested by the fact that the
parents of the proband did not display
any cutaneous phenotype. Further func-
tional studies will be needed to delineate
the functional consequences of this
recessive mutation on TRPV3 function.
In conclusion, the present study indi-
cates that OS cannot only be inherited in
a dominant and X-linked recessive fash-
ion, but also as an autosomal recessive
trait. This finding is reminiscent of pre-
vious observations (Ciubotaru et al.,
2003; Fuchs-Telem et al., 2011; Padalon-
Brauch et al., 2012) on diverging modes
of inheritance of other disorders of
cornification, in populations charac-
terized by different rates of consanguinity.
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